Surgical site infection associated with a rare agent,Chryseobacterium indologenes

Chryseobacterium indologenes is a Gram-negative, immobile, aerobic, non-fermentative, oxidase-positive bacillus. This agent isa rarely isolated multidrug-resistant nosocomial pathogen. It causes a wide range of infections such as meningitis, bacteremia,respiratory tract infections, urinary tract infections, surgical site infections, soft tissue infections, prosthesis, and catheter infections.In this article, a rare case of C. indolegenes surgical site infection following percutaneous endoscopic gastrostomy in a patienttreated for malnutrition is presented.

PDF

___

1. Mukerji R, Kakarala R, Smith SJ, et al. Chryseobacterium indologenes: an emerging infection in the USA. BMJ Case Rep 2016; bcr2016214486.
2. Kirby JT, Sader HS, Walsh TR, et al. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997- 2001). J Clin Microbiol 2004;42:445-8.
3. Das P, Karade S, Kaur K, et al. Chryseobacterium indologenes pneumonitis in an infant: A Case Report. Clin Diagn Res 2017;1:7-8.
4. Bhalla GS, Gupta S, Sarao MS, et al. Chryseobacterium indologenes: Case report of an emerging pathogen. JMMS 2018;20:70-2.
5. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, M100-S23.
6. Ceylan A, Guducuoglu H, Akbayram S, et al. Hidrosefalisi olan bir olguda Chryseobacterium indologenes ile ilişkili sepsis. Mikrobiyol Bul 2011;45:735-40.
7. Douvoyiannis M, Kalyoussef S, Philip G, et al. Chryseobacterium indologenes bacteremia in an infant. Int J Infect Dis 2010;14:531-2.
8. Hsueh PR, Teng LJ, Yang PC, et al. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis 1997;16:568-74.
9. Chen FL, Wang GC, Teng SO, et al. Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases. J Microbiol Immunol Infect 2013;46:425-32.
10. Bellais S, Poirel L, Leotard S, et al. Genetic diversity of carbapenem-hydrolyzing metallo-beta-lactamases from Chryseobacterium (Flavobacterium) indologenes. Antimicrob Agents Chemother 2000;44:3028-34.
11. Lin YT, Jeng YY, Lin ML, et al. Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia. J Microbiol Immunol Infect 2010;43:498-505.
12. Nulens E, Bussels B, Bols A, et al. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect 2001;7:391-3.